Substantial studies have recognized HO-1 as an important therapeutic target for the treatment of cardiovascular diseases with high oxidative-stress levels, such as hypertension, atherosclerosis, diabetes, obesity and myocardial ischemia-reperfusion injury [11,12,13,14]. This evidence concerns the gene HMOX1 and cardiovascular disorder.